首页> 外文期刊>Analytical Biochemistry: An International Journal of Analytical and Preparative Methods >Association of FSHR missense mutations with female infertility, in silico investigation of their molecular significance and exploration of possible treatments using virtual screening and molecular dynamics
【24h】

Association of FSHR missense mutations with female infertility, in silico investigation of their molecular significance and exploration of possible treatments using virtual screening and molecular dynamics

机译:与女性不孕症的FSHR畸打突变协会,在Silico调查他们的分子意义和使用虚拟筛选和分子动力学可能治疗的探索

获取原文
获取原文并翻译 | 示例
           

摘要

This study investigated the association of A419T (rs121909661) and T449I (rs28928870) with infertility among Iranian women and possible treatments by agonizing the mutated receptor. 151 women were genotyped at A419T and T449I sites. Homology modeling, pharmacophore modeling, virtual screening, docking and molecular dynamics (MD) were performed. A419T and T449I indicated a significant and a weak association with infertility among Iranian women (P = 0.005 and P = 0.03, respectively). Significant differences found among three genotypes of A419T with FSH (P = 0.01) and LH (P < 0.0001). G-allele carriers of A419T had susceptibility to display higher FSH and LH serum levels. In silico results revealed the most potent agonists among 3041 similar compounds and MD supported this finding. Altogether, genotyping of A419T and T449I as potential markers might be helpful in prognosis and treatment of infertility. Also, a new series of potent FSHR agonists were identified for future drug development and treatment of infertility related to FSHR dysfunction.
机译:本研究研究了A419T(RS121909661)和T449i(RS28928870)的关联,通过激动突变的受体通过令人生畏和可能的治疗方法。 151名女性在A419T和T449I位点进行基因分型。进行同源性建模,药效线建模,虚拟筛选,对接和分子动力学(MD)。 A419T和T449i表明了伊朗女性中不孕症的重要性和薄弱关联(P = 0.005和P = 0.03)。 A419T的三种基因型在FSH(P = 0.01)和LH(P <0.0001)中发现了显着差异。 A419T的G-Allele载体易于显示更高的FSH和LH血清水平。在Silico结果中,揭示了3041个类似的化合物和MD中最有效的激动剂支持这一发现。完全,A419T和T449i的基因分型作为潜在标志物可能有助于预后和治疗不孕症。此外,还确定了一系列新的有效的FSHR激动剂,用于未来的药物开发和与FSHR功能障碍相关的不孕症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号